Veytics Intelligence
2026-10-05 · Financial Times

McKesson and CD&R near $5bn-plus deal to buy infusion services provider

Acquisition of Option Care Health would be the latest buyout of an undervalued healthcare services company

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.